This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Q1 FY27 revenue down 1.7%, PAT Rs 0.28 lakh vs Rs 71.41 lakh loss
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 2.6 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone results for the quarter ended 30 June 2026: revenue from operations was Rs 850.02 lakh, down 1.7 percent from Rs 864.90 lakh a year earlier. Profit after tax was Rs 0.28 lakh versus a loss of Rs 71.41 lakh, with EPS of Rs 0.00. The prior quarter, ended 31 March 2026, posted a Rs 2.13 lakh loss. Full-year FY26 standalone loss was Rs 111.72 lakh. Auditors raised no issues. The board appointed a CEO and three independent directors.
Revenue slipped and profit is only marginal, so the turnaround from last year's loss is not yet strong for the stock.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹8.64 Cr | ₹9.47 Cr | −8.8% |
| Operating profit | −₹0.45 Cr | −₹0.21 Cr | loss widened |
| Profit after tax | −₹0.29 Cr | ₹0.15 Cr | −296.9% |
| EBITDA margin | 0.3% | 3.1% | −2.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.